Press release
Mucopolysaccharidosis Treatment Market on Track for Strong Growth, Estimated to Grow at 7.9% CAGR Through 2029
Mucopolysaccharidosis Treatment
What Is the Expected CAGR for the Mucopolysaccharidosis Treatment Market Through 2025?
In the past few years, the mucopolysaccharidosis treatment market has witnessed robust growth. The market size is projected to increase from $2.4 billion in 2024 to $2.59 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.0%. Factors such as the widespread use of enzyme replacement therapy (ERT), advancements in diagnostic tools, increased advocacy and awareness, progress in gene therapy, and the development of healthcare infrastructure have contributed to the growth during the historic period.
What's the Projected Size of the Global Mucopolysaccharidosis Treatment Market by 2029?
The market for treating mucopolysaccharidosis is projected to experience considerable growth in the following years, expanding to $3.51 billion by 2029 with a CAGR of 7.9%. This growth over the forecast period can be a result of advancements in gene editing, changes and support from regulatory authorities, initiatives focused on patient access, the rise of new therapeutic methods, and the application of precision medicine. Key trends within this timeframe may include programs supporting caregivers, attention on managing symptoms, educational and training initiatives, increased global accessibility, and progress in biomarker development.
View the full report here:
https://www.thebusinessresearchcompany.com/report/mucopolysaccharidosis-treatment-global-market-report
Top Growth Drivers in the Mucopolysaccharidosis Treatment Industry: What's Accelerating the Market?
The mucopolysaccharidosis treatment market is expected to expand due to the rising prevalence of different forms of mucopolysaccharidosis. Mucopolysaccharidosis, a type of complex carbohydrate, accumulates in body tissues if the person lacks the necessary enzyme to break it down. Mucopolysaccharidosis (MPS) treatment can help hinder the progression of the disease by reducing the formation of glycosaminoglycan (GAG) within the body, controlling the symptoms, and avoiding complications through different therapeutic methods. For instance, the Orphanet Journal of Rare Diseases, a peer-reviewed open-access medical journal based in France, reported in July 2024 that the incidence of mucopolysaccharidosis IVa (MPS IVa) is approximately 1 in 201,000 live births, though this statistic is expected to noticeably vary among different populations. Likewise, the birth prevalence of Mucopolysaccharidosis VI (MPS VI) is predicted to range between 1 in 43,261 and 1 in 1,505,160, reliant on the population. As a result, the rising prevalence of different forms of mucopolysaccharidosis will fuel the growth of the mucopolysaccharidosis treatment market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11942&type=smp
What Trends Will Shape the Mucopolysaccharidosis Treatment Market Through 2029 and Beyond?
The mucopolysaccharidosis treatment market is witnessing growing interest in product innovation as a significant trend. Prominent companies in this arena are emphasizing on introducing innovative products to reinforce their market stand. As an illustration, in September 2022, Ultragenyx Pharmaceutical Inc., a biopharmaceutical enterprise based in the US, unveiled Vestronidase alfa (Mepsevi) in Japan, developed exclusively for treating patients suffering from Mucopolysaccharidosis Type VII (MPS VII or Sly Syndrome). This pioneering enzyme replacement therapy aims at the enzyme deficiency in MPS VII, facilitating the decomposition of glycosaminoglycans (GAGs) and thereby reducing their buildup in tissues and organs. Mepsevii improves the mobility and respiratory function of patients, ushering in a transformative treatment for those grappling with this rare, escalating disorder. This endorsement represents a vital stride towards guaranteeing that patients living with rare diseases in Japan receive necessary care.
What Are the Main Segments in the Mucopolysaccharidosis Treatment Market?
The mucopolysaccharidosis treatment market covered in this report is segmented -
1) By Treatment: Enzyme Replacement Therapy, Stem Cell Therapy
2) By Disease: Mucopolysaccharidosis- I, Mucopolysaccharidosis- II, Mucopolysaccharidosis-IV, Mucopolysaccharidosis-VI, Other Diseases
3) By Route Of Administration: Intravenous, Intracerebroventricular
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Enzyme Replacement Therapy: Idursulfase (Elaprase), Laronidase (Aldurazyme), Velaglucerase Alfa (Vpriv), Galsulfase (Naglazyme)
2) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation (HSCT), Umbilical Cord Blood Transplantation, Gene Therapy Approaches
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11942&type=smp
Which Top Companies are Driving Growth in the Mucopolysaccharidosis Treatment Market?
Major companies operating in the mucopolysaccharidosis treatment market include Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., BioMarin Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Green Cross Corporation, Sarepta Therapeutics Inc., Esteve SA, JCR Pharmaceuticals Co. Ltd., Ultragenyx Pharmaceutical Inc., RegenxBio Inc., Sangamo Therapeutics Inc., Audentes Therapeutics Inc., Eidos Therapeutics Inc., Neurogene Inc., Immusoft Corporation, Bioasis Technologies Inc., Paradigm Biopharmaceuticals Ltd., Rimedion Inc., Eloxx Pharmaceuticals Inc., iBio Inc., Abeona Therapeutics Inc.
Which Regions Will Dominate the Mucopolysaccharidosis Treatment Market Through 2029?
North America was the largest region in the mucopolysaccharidosis treatment market in 2024. The regions covered in the mucopolysaccharidosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11942
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mucopolysaccharidosis Treatment Market on Track for Strong Growth, Estimated to Grow at 7.9% CAGR Through 2029 here
News-ID: 4107445 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Mucopolysaccharidosis
Mucopolysaccharidosis Treatment Market Is Going to Boom |• Sanofi • Takeda P …
Worldwide Market Reports has recently published an in-depth research study titled "Mucopolysaccharidosis Treatment Market Size and Forecast 2026-2033: Analysis by Manufacturers, Key Regions, Product Types, and Applications." The report is developed using a robust blend of primary and secondary research methodologies, ensuring accuracy, reliability, and comprehensive market coverage. Leveraging historical data and forward-looking projections, the study presents a detailed evaluation of the Mucopolysaccharidosis Treatment market growth, analyzing trends in both…
Mucopolysaccharidosis Treatment Market Trends That Will Shape the Next Decade: I …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Mucopolysaccharidosis Treatment Market Size By 2025?
The market for treatments for mucopolysaccharidosis has experienced robust expansion recently, projected to climb from a valuation of $2.4 billion in 2024 to $2.58 billion by 2025, reflecting a compound annual growth rate of 7.7%; this uptrend during the…
Mucopolysaccharidosis Market Set to Hit USD 3.65 Billion by 2034
Mucopolysaccharidosis (MPS) is a group of rare, inherited metabolic disorders caused by the absence or malfunction of enzymes needed to break down glycosaminoglycans (GAGs). These conditions, including Hurler syndrome (MPS I), Hunter syndrome (MPS II), Sanfilippo syndrome (MPS III), and others, are progressive and can affect physical and cognitive development.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71067
Over the past decade, orphan drug development, advancements in enzyme replacement therapy…
Mucopolysaccharidosis Treatment Market Analysis, Keyplayers, Share And Forecast …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Mucopolysaccharidosis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.19 billion In 2028 At…
Mucopolysaccharidosis Treatment Market Size, Trends, Leading Players, Share And …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Mucopolysaccharidosis Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The mucopolysaccharidosis treatment market size has grown strongly in recent years. It…
Gene Therapy for Mucopolysaccharidosis Market to Witness Growth Acceleration by …
Gene Therapy for Mucopolysaccharidosis Market is expected to witness moderate growth registering 9.4% CAGR during the forecast period (2023-2029).
Important changes in the business allow key players to attain larger profits. This Gene Therapy for Mucopolysaccharidosis Market study report is the best way to make changes with the help of entire market condition and metrics provided here. These metrics also allow getting ahead in the industry. Furthermore, this market report makes…
